Table 8 Clinical characteristics of CRC involving the microbiological study

Cases, n

15

13

–

Age (years)

59.53 ± 12.14

68.15 ± 9.75

0.051

Males, n

9

7

0.743

BMI (kg/m²)

22.96 ± 3.03

22.90 ± 2.91

0.956

Known hypertension, n

4

6

0.283

Known diabetes, n

2

0

0.172

Long-term Smoking history, n

3

3

0.843

Long-term drinking history, n

3

2

0.750

Red blood cells (10¹²/L)

4.38 ± 0.67

4.16 ± 0.51

0.336

Haemoglobin (g/L)

132.20 ± 21.55

124.69 ± 19.79

0.349

white blood cells (10⁹/L)

5.53 ± 1.38

4.88 ± 1.38

0.225

Blood platelet (10⁹/L)

228.73 ± 77.88

192.54 ± 52.56

0.168

Haematocrit

0.40 ± 0.06

0.40 ± 0.05

0.321

Mean red blood cell haemoglobin content

30.20 ± 1.90

29.65 ± 3.35

0.594

Mean corpuscular-haemoglobin concentration

331.40 ± 12.02

329.08 ± 13.85

0.639

Mean red blood cell volume

91.12 ± 5.27

89.90 ± 7.50

0.619

Red blood cell distribution width

12.78 ± 0.64

13.35 ± 2.12

0.332

Alanine transaminase (U/L)

15.97 ± 8.23

15.05 ± 5.40

0.732

Glutamic oxaloacetic transaminase (U/L)

18.93 ± 2.88

18.39 ± 2.18

0.585

Total protein (g/L)

66.19 ± 7.24

65.92 ± 5.39

0.910

Albumin (g/L)

37.78 ± 4.35

37.40 ± 3.86

0.810

Total bilirubin (g/L)

13.57 ± 7.79

13.00 ± 5.70

0.828

Direct bilirubin (g/L)

5.01 ± 2.62

4.60 ± 1.59

0.631

Creatinine (μmol/L)

70.61 ± 15.91

72.52 ± 15.60

0.753

Urea nitrogen (mmol/L)

5.56 ± 2.11

4.39 ± 1.43

0.101

Glucose (mmol/L)

5.13 ± 0.98

4.93 ± 0.60

0.536

CA125

10.31 ± 2.93

10.96 ± 3.17

0.579

CA153

8.09 ± 4.71

6.88 ± 3.26

0.444

CA724

2.21 ± 1.56

2.36 ± 2.20

0.843

CA199

9.12 ± 9.28

38.19 ± 50.70

0.038

CEA

19.62 ± 37.26

10.56 ± 15.23

0.421

Cytokeratin 19 fragment

1.61 ± 0.60

2.03 ± 0.84

0.137

Neuron specific enolase

11.69 ± 3.07

9.85 ± 2.09

0.102

Squamous cell carcinoma associated antigen

0.83 ± 0.59

0.73 ± 0.27

0.598

Alpha fetoprotein

3.20 ± 1.93

2.37 ± 0.74

0.154

Ki-67 (%)

61.33 ± 11.87

65.38 ± 13.91

0.413

TMN stage

 Stage II

13

8

0.126

 Stage III

2

5